Logo image of MBI

MBIA INC (MBI) Stock Fundamental Analysis

NYSE:MBI - New York Stock Exchange, Inc. - US55262C1009 - Common Stock - Currency: USD

4.76  +0.09 (+1.93%)

After market: 4.76 0 (0%)

Fundamental Rating

1

Taking everything into account, MBI scores 1 out of 10 in our fundamental rating. MBI was compared to 143 industry peers in the Insurance industry. MBI has a bad profitability rating. Also its financial health evaluation is rather negative. MBI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MBI had negative earnings in the past year.
In the past year MBI has reported a negative cash flow from operations.
In the past 5 years MBI always reported negative net income.
MBI had negative operating cash flow in 4 of the past 5 years.
MBI Yearly Net Income VS EBIT VS OCF VS FCFMBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B -1.5B

1.2 Ratios

Looking at the Return On Assets, with a value of -20.62%, MBI is doing worse than 95.80% of the companies in the same industry.
Industry RankSector Rank
ROA -20.62%
ROE N/A
ROIC N/A
ROA(3y)-15.16%
ROA(5y)-13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MBI Yearly ROA, ROE, ROICMBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

1.3 Margins

MBI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MBI Yearly Profit, Operating, Gross MarginsMBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, MBI has more shares outstanding
The number of shares outstanding for MBI has been reduced compared to 5 years ago.
MBI has a worse debt/assets ratio than last year.
MBI Yearly Shares OutstandingMBI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
MBI Yearly Total Debt VS Total AssetsMBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.2 Solvency

Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
MBI Yearly LT Debt VS Equity VS FCFMBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B 8B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MBI Yearly Current Assets VS Current LiabilitesMBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for MBI have decreased by -9.55% in the last year.
MBI shows a strong growth in Revenue. In the last year, the Revenue has grown by 583.33%.
The Revenue for MBI have been decreasing by -34.49% on average. This is quite bad
EPS 1Y (TTM)-9.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)583.33%
Revenue growth 3Y-35.84%
Revenue growth 5Y-34.49%
Sales Q2Q%11.11%

3.2 Future

MBI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.98% yearly.
Based on estimates for the next years, MBI will show a very negative growth in Revenue. The Revenue will decrease by -11.36% on average per year.
EPS Next Y83.94%
EPS Next 2Y35.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-14.29%
Revenue Next 2Y-11.36%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MBI Yearly Revenue VS EstimatesMBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
MBI Yearly EPS VS EstimatesMBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MBI. In the last year negative earnings were reported.
Also next year MBI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MBI Price Earnings VS Forward Price EarningsMBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MBI Per share dataMBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30 -40

4.3 Compensation for Growth

MBI's earnings are expected to grow with 35.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.98%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MBIA INC

NYSE:MBI (4/25/2025, 8:21:38 PM)

After market: 4.76 0 (0%)

4.76

+0.09 (+1.93%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-27 2025-02-27/amc
Earnings (Next)05-08 2025-05-08/amc
Inst Owners49.83%
Inst Owner Change-65.01%
Ins Owners11.34%
Ins Owner Change-4.43%
Market Cap239.76M
Analysts74.29
Price Target8.16 (71.43%)
Short Float %4.15%
Short Ratio4.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend7.73
Dividend Growth(5Y)97.69%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.95%
Min EPS beat(2)-90.1%
Max EPS beat(2)100%
EPS beat(4)1
Avg EPS beat(4)-509.11%
Min EPS beat(4)-1814.19%
Max EPS beat(4)100%
EPS beat(8)2
Avg EPS beat(8)-487.98%
EPS beat(12)4
Avg EPS beat(12)-350.66%
EPS beat(16)5
Avg EPS beat(16)-308.39%
Revenue beat(2)2
Avg Revenue beat(2)46.16%
Min Revenue beat(2)27.3%
Max Revenue beat(2)65.02%
Revenue beat(4)4
Avg Revenue beat(4)33.19%
Min Revenue beat(4)13.15%
Max Revenue beat(4)65.02%
Revenue beat(8)8
Avg Revenue beat(8)27.58%
Revenue beat(12)12
Avg Revenue beat(12)139.28%
Revenue beat(16)15
Avg Revenue beat(16)160.02%
PT rev (1m)18.52%
PT rev (3m)18.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)22.22%
EPS NY rev (1m)0%
EPS NY rev (3m)22.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.85
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.9
EYN/A
EPS(NY)-0.63
Fwd EYN/A
FCF(TTM)-3.49
FCFYN/A
OCF(TTM)-3.49
OCFYN/A
SpS0.81
BVpS-41.22
TBVpS-41.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.62%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-15.16%
ROA(5y)-13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y83.94%
EPS Next 2Y35.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)583.33%
Revenue growth 3Y-35.84%
Revenue growth 5Y-34.49%
Sales Q2Q%11.11%
Revenue Next Year-14.29%
Revenue Next 2Y-11.36%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y9.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.74%
OCF growth 3YN/A
OCF growth 5YN/A